Reaktionsgleichung
[C:1]([O:5][C:6](=[O:24])[NH:7][C@@H:8]1[C:14](=[O:15])[NH:13][C:12]2[CH:16]=[CH:17][CH:18]=[CH:19][C:11]=2[C:10]2[CH:20]=[CH:21][CH:22]=[CH:23][C:9]1=2)([CH3:4])([CH3:3])[CH3:2].Br[CH2:26][CH2:27][O:28][CH2:29][C:30]1[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=1>>[C:1]([O:5][C:6](=[O:24])[NH:7][C@@H:8]1[C:14](=[O:15])[N:13]([CH2:26][CH2:27][O:28][CH2:29][C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][CH:31]=2)[C:12]2[CH:16]=[CH:17][CH:18]=[CH:19][C:11]=2[C:10]2[CH:20]=[CH:21][CH:22]=[CH:23][C:9]1=2)([CH3:4])([CH3:2])[CH3:3]Komponenten
3
Versuchsvorschrift
Using ((S)-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)-carbamic acid tert-butyl ester and benzyl 2-bromoethyl ether, the title compound was prepared in the same manner as described for example 1a. White crystals, mp. 132-134° C. (84%). MS: m/e=459(M+H+), mp 133° C.
Quellen und Nachweise
- ORD-Eintrag
- ord-b10b5b2464b44662a61ec1b7d73d2581
- Quelldatensatz
- uspto-grants-2008_09
- Patentnummer
- US07425551B2
Verknüpfte Notizen
Wird geladen…